New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
18:36 EDTALNYAlnylam aims to advance ALN-TTR02 into Phase III pivotal trial
Alnylam aims to advance ALN-TTR02 into Phase III pivotal trial in Transthyretin, TTR -mediated amyloidosis, ATTR, Patients with Familial Amyloidotic Polyneuropathy, FAP, by late 2013; Phase II data expected in mid-2013.
News For ALNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
06:08 EDTALNYAlnylam 4.737M share Secondary priced at $95.00
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use